Recent advances in treatment

Considers recent advances in treatment, including the clinical trial evidence supporting treatment with fenfluramine and cannabidiol, and a summary of products on the horizon.


These three clinical papers have been chosen by our experts to give you the opportunity to explore these topics in greater depth. They include an overview of the treatment of Dravet syndrome with antiepileptic drugs and the ketogenic diet; one of the key phase 3 trials of fenfluramine in patients taking stiripentol; and a real-world study of add-on therapy with fenfluramine.


This infographic for provides an overview of the efficacy and tolerability of fenfluramine and cannabidiol and outlines potential future treatments.

KOL Commentaries

In this video, Dr Nicola Specchio, Professor Renzo Guerrini and Professor Rima Nabbout discuss their experience of treating patients with Dravet syndrome with fenfluramine and cannabidiol in clinical trials and in the real-world setting, and review their place in management.

This site is only for use by healthcare professionals.

By continuing to view this site you are confirming that you are a healthcare professional.